BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3669780)

  • 1. Specificity of fibrinopeptide A (FpA) as a marker for gastrointestinal cancers before and after surgery.
    Abbasciano V; Levato F; Zavagli G
    Med Oncol Tumor Pharmacother; 1987; 4(2):75-9. PubMed ID: 3669780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinopeptide A and the phosphate content of fibrinogen in venous thromboembolism and disseminated intravascular coagulation.
    Leeksma OC; Meijer-Huizinga F; Stoepman-van Dalen EA; van Ginkel CJ; van Aken WG; van Mourik JA
    Blood; 1986 May; 67(5):1460-7. PubMed ID: 3697510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth.
    Rickles FR; Edwards RL; Barb C; Cronlund M
    Cancer; 1983 Jan; 51(2):301-7. PubMed ID: 6821818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of fibrinopeptide A in surgery].
    Fuwa S
    Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):191-205. PubMed ID: 6236358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinopeptide A and B beta 15-42 in liver cirrhosis.
    Marongiu F; Mameli G; Acca MR; Mulas G; Medda A; Tronci MB; Mamusa AM; Balestrieri A
    Haemostasis; 1988; 18(2):126-8. PubMed ID: 2457543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of fibrinopeptide A and fibrinopeptide B beta 15-42 in glomerulonephritis and the nephrotic syndrome.
    Tomura S; Oono Y; Kuriyama R; Takeuchi J
    Arch Intern Med; 1985 Jun; 145(6):1033-5. PubMed ID: 4004427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes.
    Jones RL
    Diabetes; 1985 Sep; 34(9):836-43. PubMed ID: 4029510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The activation of the blood coagulation system in cancer patients: the fibrinopeptide A level and its relationship to tumor spread].
    Riabov GA; Pasechnik IN
    Gematol Transfuziol; 1992; 37(7-8):23-5. PubMed ID: 1342980
    [No Abstract]   [Full Text] [Related]  

  • 10. Performance characteristics of a simple radioimmunoassay for fibrinopeptide A.
    Walenga JM; Hoppensteadt D; Emanuele RM; Fareed J
    Semin Thromb Hemost; 1984 Oct; 10(4):219-27. PubMed ID: 6515418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.
    Cronlund M; Hardin J; Burton J; Lee L; Haber E; Bloch KJ
    J Clin Invest; 1976 Jul; 58(1):142-51. PubMed ID: 932202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y; Abe T
    Thromb Haemost; 1981 Dec; 46(4):706-9. PubMed ID: 7330820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A method for the assay of fibrinopeptide in plasma].
    Piana A; Armani U; Saccarello A; Boeri D; Maiello M; Falzetti G
    Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1558-61. PubMed ID: 6661319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinopeptide A and intravascular coagulation in normotensive and hypertensive pregnancy and parturition.
    Wallmo L; Karlsson K; Teger-Nilsson AC
    Acta Obstet Gynecol Scand; 1984; 63(7):637-40. PubMed ID: 6516813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta].
    Touho H; Hino A; Suzuki K; Kubo T; Hirakawa K
    No To Shinkei; 1984 Oct; 36(10):1009-14. PubMed ID: 6518124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmatic parameters of fibrin formation and degradation in cancer patients: correlation between fibrinopeptide A and D-dimer.
    Sagripanti A; Carpi A; Baicchi U; Grassi B
    Biomed Pharmacother; 1993; 47(6-7):235-9. PubMed ID: 8061250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinopeptide A during normal pregnancy.
    Romero R; Rickles FR; Matthews E; Scott D; Dinan C; Duffy T
    Am J Perinatol; 1988 Jan; 5(1):70-3. PubMed ID: 3257391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycemia may determine fibrinopeptide A plasma level increase in humans.
    Ceriello A; Giugliano D; Quatraro A; Dello Russo P; Marchi E; Torella R
    Metabolism; 1989 Dec; 38(12):1162-3. PubMed ID: 2593829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
    Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
    Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood coagulation and fibrinolysis in anesthesia and operations, with special reference to FPA, FPB beta 15-42].
    Gando S; Tedo I; Hanaoka Y; Makise N; Tsujinaga H; Kubota M
    Masui; 1988 Apr; 37(4):451-6. PubMed ID: 3398226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.